Elmiron was originally approved for use by the FDA to treat the symptoms of Interstitial Cystitis in 1996. Research has established a link between the long-term use of Elmiron and injury to the center of the retina.
This condition, Retinal Maculopathy, includes symptoms that occur gradually, and may not be immediately obvious. They include dark spots in the field of vision, difficulty adjusting vision to low-light situations, difficulty reading, blurred vision, and even blindness. Click here to watch this video and learn more.
Allergan texturized breast implants and tissue expanders are linked to a type of Non-Hodgkin’s Lymphoma called Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Allergan did not warn women of this risk, and hundreds of thousands of women are potentially affected. BIA-ALCL on average, takes up to 9 years to manifest as cancer, and Allergan products are responsible for over 80% of the reported breast implant-related cancers. Click here to watch this video and learn more.
The underdeveloped gastrointestinal tract of a premature infant cannot tolerate cow’s milk products shortly after birth. The use of these types of formulas during this stage increases the risk of Necrotizing Enterocolitis (NEC), a serious intestinal condition with a high mortality rate.
Similac and Enfamil, the manufacturers of cow’s milk-based formulas, knew the risks, and did not warn parents and healthcare providers. Click here to watch this video and learn more.
There are many different types of technology and devices that can be used to enable children with CP to advance communications, learning, hearing, and mobility. The use of assistive technology can help to improve a child’s quality of life and ease their transition into independent adulthood.
Click here to see some examples of technology being used to make a difference for a child with CP.